Advent International and Warburg Pincus have selected Franco Negron to be chief executive officer of BioPharma Solutions following its proposed divestiture from Baxter International Inc.

Negron has nearly 30 years of experience in the pharmaceutical industry. Most recently, he served for three years as the CEO of ApiJect Systems America. Prior to joining ApiJect, Negron held leadership roles including president of commercial operations at Thermo Fisher Scientific and president of development and commercial, North America. Negron has also held senior positions at other pharmaceutical companies, including Valeant Pharmaceuticals, Novartis and McNeil Consumer Healthcare.